Omniparticle Contrast Agent for Multimodal Imaging: Synthesis and Characterization in an Animal Model

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Medical Imaging

Background:

• Individual imaging modalities possess unique strengths but also limitations.
• Overcoming these drawbacks requires synergistic approaches and advanced contrast agents.
• Multimodal imaging offers comprehensive diagnostic information by integrating data from various techniques.

Purpose of the Study:

• To develop a novel, single-administration contrast agent for diverse imaging modalities.
• To enhance collaboration between different imaging research fields.
• To enrich diagnostic information obtainable from individual imaging techniques.

Main Methods:

• Synthesized dextran-coated iron oxide nanoparticles conjugated with a fluorophore, thyroxine, and radioisotope chelators.
• Utilized a modified co-precipitation method for nanoparticle synthesis.
• Conducted in vitro studies (cell uptake, viability, phantoms) and in vivo studies (intraductal injection, tumor model).

Main Results:

• The synthesized agent produced signals across MRI, MPI, fluorescence, photoacoustic, CT, and PET imaging.
• In vitro studies showed concentration-dependent uptake without significant toxicity.
• In vivo studies demonstrated successful localization and signal generation in mouse models, with CT excelling in ductal imaging.

Conclusions:

• A fully functional omniparticle contrast agent was successfully synthesized and validated in vitro and in vivo.
• The agent demonstrated potent signal generation across multiple imaging modalities without adverse toxicity.
• Future applications include exploration in human disease models for image-guided diagnostics and therapeutics.